28
Participants
Start Date
November 28, 2023
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2026
Nuwiq
Nuwiq is a purified B-domain-deleted FVIII glycoprotein synthesised by a genetically engineered human embryonic kidney cell line (HEK 293F).
RECRUITING
UT Southwestern Medical Center, Dallas
RECRUITING
University Hospital Centre Zagreb, Zagreb
RECRUITING
Helsinki University Hospital, Helsinki
RECRUITING
CHU de Nantes Hôtel-Dieu, Nantes
RECRUITING
CHRU de Tours, Tours
RECRUITING
Vivantes Klinikum im Friedrichshein (KFH), Berlin
RECRUITING
Gerinnungszentrum Rhein-Ruhr, Duisburg
RECRUITING
Universitätsklinikum Hamburg Eppendorf (UKE), Hamburg
RECRUITING
Christian Medical College Vellore, Vellore
NOT_YET_RECRUITING
St. John's Medical College Hospital, Bengaluru
RECRUITING
Azienda Ospedaliera Pugliese Ciaccio, Catanzaro
RECRUITING
Azienda Ospedaliero Universitaria Careggi - Centro Emofilia, Florence
RECRUITING
Centro Trombosi e Malattie Emorragiche, ITCCS Humanitas Research Hospital, Milan
RECRUITING
Centre for Haemopilia, Institute for transfusion medicine of Republic of North Macedonia, Skopje
RECRUITING
Clinical Center for Serbia Belgrade, Belgrade
RECRUITING
Hospital Universitario La Paz, Madrid
RECRUITING
Hospital Universitario Virgen del Rocio, Seville
NOT_YET_RECRUITING
St. James's University Hospital, Leeds
Lead Sponsor
Octapharma
INDUSTRY